This work is licensed under the Creative Commons Attribution 4.0 International License.
Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care. 2004;8(4):222–6.Linde-ZwirbleWTAngusDCSevere sepsis epidemiology: sampling, selection, and society2004842226Search in Google Scholar
Chatterjee S, Bhattacharya M, Todi SK. Epidemiology of Adult-population Sepsis in India: A Single Center 5 Year Experience. Indian J Crit Care Med. 2017;21(9):573–7.ChatterjeeSBhattacharyaMTodiSKEpidemiology of Adult-population Sepsis in India: A Single Center 5 Year Experience20172195737Search in Google Scholar
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10.SingerMDeutschmanCSSeymourCWShankar-HariMThe Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)2016315880110Search in Google Scholar
Gaddam BK, Narayanan M. Study of serum HDL-cholesterol levels in sepsis patients and its prognostic significance. Int J Adv Med. 2019;6(2):312–17.GaddamBKNarayananMStudy of serum HDL-cholesterol levels in sepsis patients and its prognostic significance20196231217Search in Google Scholar
Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly. 2005;135(31–32):451–60.Christ-CrainMMullerBProcalcitonin in bacterial infections-hype, hope, more or less?200513531–3245160Search in Google Scholar
Cioccari L, Luethi N, Masoodi M. Lipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine. Front Immunol. 2020; 11:599853.CioccariLLuethiNMasoodiMLipid Mediators in Critically Ill Patients: A Step Towards Precision Medicine202011599853Search in Google Scholar
van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med. 2003;31(5):1359–66.van LeeuwenHJHeeziusECDallingaGMLipoprotein metabolism in patients with severe sepsis2003315135966Search in Google Scholar
Badellino KO, Wolfe ML, Reilly MP, Rader DJ. Endothelial lipase is increased in vivo by inflammation in humans. Circulation. 2008;117(5):678–85.BadellinoKOWolfeMLReillyMPRaderDJEndothelial lipase is increased in vivo by inflammation in humans2008117567885Search in Google Scholar
Tanaka S, Couret D, Tran-Dinh A, et al. High-density lipoproteins during sepsis: from bench to bedside. Crit Care. 2020;24(1):134.TanakaSCouretDTran-DinhAHigh-density lipoproteins during sepsis: from bench to bedside2020241134Search in Google Scholar
Rapsang AG, Shyam DC. Scoring systems in the intensive care unit: A compendium. Indian J Crit Care Med. 2014;18(4):220–8.RapsangAGShyamDCScoring systems in the intensive care unit: A compendium20141842208Search in Google Scholar
Badrinath K, Shekhar M, Sreelakshmi M, et al. Comparison of Various Severity Assessment Scoring Systems in Patients with Sepsis in a Tertiary Care Teaching Hospital. Indian J Crit Care Med. 2018;22(12):842–845.BadrinathKShekharMSreelakshmiMComparison of Various Severity Assessment Scoring Systems in Patients with Sepsis in a Tertiary Care Teaching Hospital20182212842845Search in Google Scholar
APACHE II – ClinCalc. http:// ClinCalc.com>ICU Mortality>APACHE II.APACHE II – ClinCalchttp:// ClinCalc.com>ICU Mortality>APACHE II.Search in Google Scholar
Rudd KE, Johnson SC, Agesa KM, et al. D. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020; 395:200–11.RuddKEJohnsonSCAgesaKMD.Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study202039520011Search in Google Scholar
Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ 2016;353: i1585.GottsJEMatthayMASepsis: pathophysiology and clinical management2016353i1585Search in Google Scholar
https://www.who.int/news-room/fact-sheets/detail/sepsis.https://www.who.int/news-room/fact-sheets/detail/sepsis.Search in Google Scholar
Napolitano LM. Sepsis 2018: Definitions and Guideline Changes. Surg Infect (Larchmt). 2018;19(2):117–25.NapolitanoLMSepsis 2018: Definitions and Guideline Changes201819211725Search in Google Scholar
Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017; 5:51.VijayanALVanimayaRavindranSProcalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy2017551Search in Google Scholar
Dahaba AA, Hagara B, Fall A, et al. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth. 2006;97(4):503–8.DahabaAAHagaraBFallAProcalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis20069745038Search in Google Scholar
Brunkhorst FM, Al-Nawas B, Krummenauer F, Forycki ZF, Shah PM. Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia. Clin Microbiol Infect. 2002;8(2):93–100.BrunkhorstFMAl-NawasBKrummenauerFForyckiZFShahPMProcalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia20028293100Search in Google Scholar
Yunus I, Fasih A, Wang Y. The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One. 2018;13(11): e0206527.YunusIFasihAWangYThe use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics20181311e0206527Search in Google Scholar
Rashwan D, Al Kassem Rashwan SA, Hassan WF, Sayem DM. Prognostic Value of Serum Cholesterol and Triglyceride in Septic and Non-septic Patients: Randomized Double-blinded Study. J Intensive & Crit Care. 2019;1:1–7.RashwanDAl Kassem RashwanSAHassanWFSayemDMPrognostic Value of Serum Cholesterol and Triglyceride in Septic and Non-septic Patients: Randomized Double-blinded Study2019117Search in Google Scholar
Sunayana P, Renymol B, Ambili N. Fasting Lipid Profile and Disease Severity in Sepsis Patients. Journal of Clinical and Diagnostic Research. 2017;11(11): OC10–OC12.SunayanaPRenymolBAmbiliNFasting Lipid Profile and Disease Severity in Sepsis Patients20171111OC10OC12Search in Google Scholar
Cetinkaya A, Erden A, Avci D, et al. Is hypertriglyceridemia a prognostic factor in sepsis? Ther Clin Risk Manag. 2014; 10:147–50.CetinkayaAErdenAAvciDIs hypertriglyceridemia a prognostic factor in sepsis?20141014750Search in Google Scholar
Sharma NK, Ferreira BL, Tashima AK, et al. Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis. Clin Proteomics. 2019; 16:29.SharmaNKFerreiraBLTashimaAKLipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis20191629Search in Google Scholar
Morin EE, Guo L, Schwendeman A, Li XA. HDL in sepsis - risk factor and therapeutic approach. Front Pharmacol. 2015;6:244.MorinEEGuoLSchwendemanALiXAHDL in sepsis - risk factor and therapeutic approach20156244Search in Google Scholar
Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med. 2005;33(8):1688–93.ChienJYJerngJSYuCJYangPCLow serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis2005338168893Search in Google Scholar
Maile MD, Sigakis MJ, Stringer KA, Jewell ES, Engoren MC. Impact of the pre-illness lipid profile on sepsis mortality. J Crit Care. 2020;57:197–202.MaileMDSigakisMJStringerKAJewellESEngorenMCImpact of the pre-illness lipid profile on sepsis mortality202057197202Search in Google Scholar
Chang L, Chen X, Lian C. The association between the non-HDL-cholesterol to HDL-cholesterol ratio and 28-day mortality in sepsis patients: a cohort study. Sci Rep. 2022;12(1):3476.ChangLChenXLianCThe association between the non-HDL-cholesterol to HDL-cholesterol ratio and 28-day mortality in sepsis patients: a cohort study20221213476Search in Google Scholar